CellWell record HH-0430
Optimizing the Time and Dose of Melatonin as a Sleep-Promoting Drug: A Systematic Review of Randomized Controlled Trials and Dose-Response Meta-Analysis
Cruz-Sanabria F; Bruno S; Crippa A; Frumento P; Scarselli M; Skene DJ; Faraguna U
Journal of Pineal Research ยท 2024
In plain language
This dose-response meta-analysis found melatonin's benefit for reducing sleep onset latency peaked around 3 to 5 mg per day, with diminishing added benefit at higher doses.
- Design
- Meta-analysis
Cite this record: https://thecellwell.org/studies/HH-0430
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.